Clinical Trial Update: Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Holmium-166 DOTMP plus Melphalan and peripheral stem cell transplantation in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Holmium-166 DOTMP (holmium-166 DOTMP)
• Melphalan (Melphalan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED